National Cancer Centre, Singapore

This study tests whether adding the chemotherapy drug S-1 to the targeted therapy osimertinib can shrink tumors in people with EGFR-mutant lung cancer that has stopped responding to treatment. About 30 adults with advanced lung cancer will receive the combination and be monitored…

This study looks at whether a specially trained support coordinator can help women with advanced or high-risk breast cancer feel heard and understood. About 28 women will take part in this pilot program at the National Cancer Centre Singapore. The coordinator will provide emotion…

This early-stage study tests a method called PIPAC, which sprays chemotherapy directly into the abdomen as a fine mist. It aims to ease symptoms in people with advanced cancer that has spread to the lining of the belly and who cannot have surgery. The main goal is to see if the p…